| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
|
Mol Cancer
|
2006
|
2.70
|
|
2
|
Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125.
|
J Biol Chem
|
2003
|
1.63
|
|
3
|
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.
|
Mol Cancer
|
2010
|
1.30
|
|
4
|
Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
|
Immunology
|
2007
|
1.16
|
|
5
|
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
|
Mol Cancer
|
2014
|
1.10
|
|
6
|
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.
|
Mol Cancer
|
2010
|
1.06
|
|
7
|
Expression and roles of Slit/Robo in human ovarian cancer.
|
Histochem Cell Biol
|
2011
|
1.02
|
|
8
|
Murine and human zona pellucida 3 derived from mouse eggs express identical O-glycans.
|
Proc Natl Acad Sci U S A
|
2003
|
0.96
|
|
9
|
Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting.
|
J Leukoc Biol
|
2011
|
0.95
|
|
10
|
Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats.
|
BMC Struct Biol
|
2009
|
0.93
|
|
11
|
The detection, treatment, and biology of epithelial ovarian cancer.
|
J Ovarian Res
|
2010
|
0.92
|
|
12
|
Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53.
|
PLoS One
|
2012
|
0.90
|
|
13
|
Endothelial caveolar hub regulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation.
|
Hypertension
|
2012
|
0.89
|
|
14
|
Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
|
Cancer Immunol Immunother
|
2011
|
0.88
|
|
15
|
Differential O-glycosylation of a conserved domain expressed in murine and human ZP3.
|
Biochemistry
|
2006
|
0.88
|
|
16
|
Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies.
|
J Ovarian Res
|
2009
|
0.87
|
|
17
|
The expression of free oligosaccharides in human seminal plasma.
|
J Biol Chem
|
2002
|
0.86
|
|
18
|
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy.
|
J Cancer
|
2011
|
0.86
|
|
19
|
The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.
|
Am J Reprod Immunol
|
2012
|
0.82
|
|
20
|
Analysis of protein-linked glycosylation in a sperm-somatic cell adhesion system.
|
Glycobiology
|
2007
|
0.82
|
|
21
|
Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.
|
Pharm Res
|
2015
|
0.80
|
|
22
|
Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells.
|
Reprod Sci
|
2013
|
0.76
|
|
23
|
Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.
|
Gynecol Oncol
|
2009
|
0.75
|
|
24
|
RT-SVR+q: a strategy for post-Mascot analysis using retention time and q value metric to improve peptide and protein identifications.
|
J Proteomics
|
2011
|
0.75
|
|
25
|
Plasmonic Nanoparticle-based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer.
|
ACS Sens
|
2020
|
0.75
|